CDK4 and nasopharyngeal carcinoma: The results showed that icaritin downregulated the expression of cyclin D1, CDK2, and CDK4 in a dose-dependent manner (Figures 5C,D), further demonstrating that icaritin caused S-phase arrest in nasopharyngeal carcinoma cells.